CLDF Title
Home | Contact Us | Bookmark
HEPATITIS
HBV HCV HDV
CIRRHOSIS
CIRRHOSIS HEPATIC ENCEPHALOPATHY (HE) HEPATORENAL SYNDROME (HRS) THROMBOCYTOPENIA
NASH
CHOLESTATIC
PRIMARY BILIARY CHOLANGITIS (PBC)
HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
About CLDF
Board of Trustees Board of Advisors/Faculty CLDF Committees 2022 GI Fellow Board of Advisors
Embassy of Education  
Slide Library Webcasts
 
HE-Single Disease Content  
Recorded Educational Webinar

Webcasts
     
Hepatic Encephalopathy   Educational Webcast
Expert Insights: Improving Outcomes in Patients with Chronic Liver Disease   Educational Webcast
Complications of cirrhosis   Recorded Webinar
Clinical Insights into the Management of the Complications of Cirrhosis   CME Audiocast
Featured Resources

 
Dynamic CME Resource Library
     
Hepatic Encephalopathy Update: Reports from the 64th Annual Meeting of the American Association for the Study of Liver Diseases   Educational eNewsletter
Hepatic Encephalopathy Update: Reports from the 2013 American College of Gastroenterology Meeting   Educational eNewsletter
Hepatic Encephalopathy Update: Reports From the 2013 Digestive Disease Week Annual Meeting   Educational eNewsletter
Hepatic Encephalopathy Update: Reports from the 2013 International Liver Conference   Educational eNewsletter
Hepatic Encephalopathy: A Review of Diagnostic Methods   Educational eNewsletter
 
Slide Library
   Released: 2022
test
Expert Insights: Improving Outcomes in Patients with Chronic Liver Disease
46 slides
 
 
   Released: 2020
test
Complications of Cirrhosis
65 slides
 
 
 
 
Abstract Library
1.North American Practice-Based Recommendations for Transjugular Intrahepatic Portosystemic Shunts in Portal Hypertension
 

Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36.doi: 10.1016/j.cgh.2021.07.018. Epub 2021 Jul 15.

Justin R Boike 1, Bartley G Thornburg 2, Sumeet K Asrani 3, Michael B Fallon 4, Brett E Fortune 5, Manhal J Izzy 6, Elizabeth C Verna 7, Juan G Abraldes 8, Andrew S Allegretti 9, Jasmohan S Bajaj 10, Scott W Biggins 11, Michael D Darcy 12, Maryjane A Farr 13, Khashayar Farsad 14, Guadalupe Garcia-Tsao 15, Shelley A Hall 16, Caroline C Jadlowiec 17, Michael J Krowka 18, Jeanne Laberge 19, Edward W Lee 20, David C Mulligan 21, Mitra K Nadim 22, Patrick G Northup 23, Riad Salem 2, Joseph J Shatzel 24, Cathryn J Shaw 25, Douglas A Simonetto 26, Jonathan Susman 27, K Pallav Kolli 19, Lisa B VanWagner 28, Advancing Liver Therapeutic Approaches (ALTA) Consortium
 
2.Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts
 

Dig Liver Dis. 2022 Aug;54(8):1060-1065. doi: 10.1016/j.dld.2021.12.015. Epub 2022 Jan 17.

Silvia Nardelli 1, Oliviero Riggio 2, Stefania Gioia 2, Manuela Merli 2, Alessandra Spagnoli 3, Michele di Martino 4, Giuseppe Pelle 5, Lorenzo Ridola 2
 
3.Inadequate practices for hepatic encephalopathy management in the inpatient setting
 

J Hosp Med. 2022 Aug;17 Suppl 1:S8-S16. doi: 10.1002/jhm.12897.

Jawaid Shaw 1, Lisa Beyers 2, Jasmohan S Bajaj 3
 
4.Hepatic Encephalopathy: Diagnosis and Treatment in Advanced Liver Disease
 

Crit Care Nurs Clin North Am. 2022 Sep;34(3):331-339.doi: 10.1016/j.cnc.2022.04.011.

Vickie Reed 1
 
5.Specific Challenges in Geriatric Cirrhosis and Hepatic Encephalopathy
 

Clin Gastroenterol Hepatol. 2022 Aug;20(8S):S20-S29.doi: 10.1016/j.cgh.2022.04.035.

Jasmohan S Bajaj 1, Angela Gentili 2, James B Wade 3, Michael Godschalk 2
 
6.Hepatic encephalopathy and strategies to prevent readmission from inadequate transitions of care
 

J Hosp Med. 2022 Aug;17 Suppl 1:S17-S23. doi: 10.1002/jhm.12896.

Craig Rosenstengle 1, Sunil Kripalani 2, Robert S Rahimi 3
 
7.EASL Clinical Practice Guidelines on the management of hepatic encephalopathy
 

J Hepatol. 2022 Sep;77(3):807-824. doi: 10.1016/j.jhep.2022.06.001.Epub 2022 Jun 17.

European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver
 
8.Early Liver Transplantation for Severe Alcohol-Associated Hepatitis and a History of Prior Liver Decompensation
 

Am J Gastroenterol. 2022 Jul 11. doi: 10.14309/ajg.0000000000001901. Online ahead of print.

Ethan M Weinberg 1, Matthew Dukewich 2, Neha Jakhete 3, Elizabeth Stonesifer 3, Gene Y Im 4, Michael R Lucey 5, Kirti Shetty 3, John P Rice 5, David W Victor 3rd 6, Mark R Ghobrial 6, Akshay Shetty 6, Stephanie M Rutledge 7, Sander S Florman 4, Christine Hsu 8, Mohamed Shoreibah 9, Mahmoud Aryan 10, Babak J Orandi 11, Hyosun Han 12, Norah Terrault 12, Brian P Lee 12
 
9.Use of Lactulose to Treat Hyperammonemia in ICU Patients Without Chronic Liver Disease or Significant Hepatocellular Injury
 

J Intensive Care Med. 2022 May;37(5):698-706.doi: 10.1177/08850666211023004. Epub 2021 Jun 8.

Nathan S Cutler 1, Brett W Sadowski 2, Drew A MacGregor 3
 
10.Hip Fractures in Patients With Liver Cirrhosis: Worsening Liver Function Is Associated with Increased Mortality
 

Clin Orthop Relat Res. 2022 Jun 1;480(6):1077-1088. doi: 10.1097/CORR.0000000000002088.Epub 2021 Dec 31.

Dennis Hundersmarck 1 2, Olivier Q Groot 1, Henk J Schuijt 1, Falco Hietbrink 2, Luke P H Leenen 2, Marilyn Heng 1
 
11.Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-Controlled Trials
 

Clin Gastroenterol Hepatol. 2022 Jun 21;S1542-3565(22)00595-X.doi: 10.1016/j.cgh.2022.05.042. Online ahead of print.

Jasmohan S Bajaj 1, Tarek I Hassanein 2, Nikolaos T Pyrsopoulos 3, Arun J Sanyal 4, Robert S Rahimi 5, Zeev Heimanson 6, Robert J Israel 6, Don C Rockey 7
 
12.Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door
 

Dig Dis Sci. 2022 Jun;67(6):1994-2004. doi: 10.1007/s10620-021-07075-2.Epub 2021 Jun 24.

Catherine T Frenette 1, Cynthia Levy 2, Sammy Saab 3
 
13.A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Hepatic Encephalopathy and Clostridioides difficile Infection in Patients With Cirrhosis
 

Cureus. 2022 May 31;14(5):e25537. doi: 10.7759/cureus.25537.eCollection 2022 May.

Kyaw Min Tun 1, Annie S Hong 2, Kavita Batra 3, Yassin Naga 1, Gordon Ohning 2
 
14.Nutrition Assessment and Management in Patients with Cirrhosis and Cognitive Impairment: A Comprehensive Review of Literature
 

J Clin Med. 2022 May 18;11(10):2842. doi: 10.3390/jcm11102842.

Jessica Faccioli 1, Silvia Nardelli 1, Stefania Gioia 1, Oliviero Riggio 1, Lorenzo Ridola 1
 
15.Nitrogenous compounds in the saliva and blood of cirrhotic patients: a cross-sectional study
 

Clin Oral Investig. 2022 Jun;26(6):4587-4592. doi: 10.1007/s00784-022-04426-9.Epub 2022 Feb 28.

Nathália Tuany Duarte 1, Jefferson R Tenório 2, Natália Silva Andrade 3, Fabiana Martins 4, Marina Gallottini 1, Karem L Ortega 5
 
16.Hepatic Encephalopathy by Manganese Deposition: A Case Report and a Review of Literature
 

Rev Recent Clin Trials. 2022 Jun 17.doi: 10.2174/1574887117666220617104539. Online ahead of print.

Ludovico Abenavoli 1, Giulia Fabiano 1, Anna Caterina Procopio 1, Isabella Aquila 2, Rinaldo Pellicano 3, Stefania Barone 2, Maurizio Morelli 2, Francesco Luzza 1
 
17.Hepatic encephalopathy
 

Nat Rev Dis Primers. 2022 Jun 23;8(1):43. doi: 10.1038/s41572-022-00366-6.

Dieter Häussinger 1, Radha K Dhiman 2, Vicente Felipo 3, Boris Görg 4, Rajiv Jalan 5 6, Gerald Kircheis 7, Manuela Merli 8, Sara Montagnese 9, Manuel Romero-Gomez 10, Alfons Schnitzler 11, Simon D Taylor-Robinson 12, Hendrik Vilstrup 13
 
18.The role of TIPS in patients with cirrhosis and ascites: recent evolution and open questions
 

Pierre Deltenre # 1 2 3, Alberto Zanetto # 4 5, Dario Saltini 4, Christophe Moreno 1 6, Filippo Schepis 4
 
19.Patients with type 2 diabetes and elevated fibrosis-4 are under-referred to hepatology and have unrecognized hepatic decompensation
 

J Gastroenterol Hepatol. 2022 May 25. doi: 10.1111/jgh.15900. Online ahead of print.

Winston Dunn 1, Xing Song 2, Devin Koestler 3, Kristine Grdinovac 1, Eyad Al-Hihi 1, G John Chen 2, Ryan Taylor 1, Jessica Wilson 1, Steven Weinman 1
 
20.Rethinking the management of pain in cirrhosis: toward precision therapy for pain
 

Hepatology. 2022 Jun 5. doi: 10.1002/hep.32598. Online ahead of print.

Alexis Holman 1, Neehar Parikh 2, Dan J Clauw 3, David A Williams 3, Elliot B Tapper 2
 
21.Management of Hepatic Encephalopathy Associated with Advanced Liver Disease
 

Clin Drug Investig. 2022 May 10. doi: 10.1007/s40261-022-01146-6.Online ahead of print

Rita García-Martínez 1 2 3 4, Raquel Diaz-Ruiz 5, Marta Poncela 5
 
22.Area Deprivation Index and Gut-Brain Axis in Cirrhosis
 

Clin Transl Gastroenterol. 2022 May 10. doi: 10.14309/ctg.0000000000000495.Online ahead of print.

Jasmohan S Bajaj 1, Andrew Fagan 1, Sara McGeorge 1, Richard K Sterling 1, Shari Rogal 2, Masoumeh Sikaroodi 3, Patrick M Gillevet 3
 
23.Newly Diagnosed Hepatic Encephalopathy Presenting as Non-convulsive Status Epilepticus: A Case Report and Literature Review
 

Front Neurol. 2022 May 12;13:880068. doi: 10.3389/fneur.2022.880068.eCollection 2022.

Marco Olivero 1, Delia Gagliardi 1 2, Gianluca Costamagna 1, Daniele Velardo 2, Francesca Magri 3, Fabio Triulzi 4, Giorgio Conte 4, Giacomo P Comi 1 3, Stefania Corti 1 2, Megi Meneri 1 2
 
24.Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy
 

Ann Pharmacother. 2022 Jun 5;10600280221100537. doi: 10.1177/10600280221100537.Online ahead of print.

Ann Marie Stoll 1, Maria Guido 1 2, Alicia Pence 3, Anthony J Gentene 1 2
 
25.Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort
 

Clin Gastroenterol Hepatol. 2022 Apr 15;S1542-3565(22)00388-3.doi: 10.1016/j.cgh.2022.03.046. Online ahead of print.

Jasmohan S Bajaj 1, Puneeta Tandon 2, Jacqueline G O'Leary 3, K Rajender Reddy 4, Guadalupe Garcia-Tsao 5, Paul Thuluvath 6, Jennifer C Lai 7, Ram M Subramanian 8, Hugo E Vargas 9, Florence Wong 10, Andrew Fagan 11, Sara McGeorge 11, Leroy R Thacker 11, Patrick S Kamath 12
 
View More
 
 

HEPATITIS

HBV
HCV
HDV

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

NASH

Webcasts
Slide Library
Abstract Library

CHOLESTATIC

PBC

HCC

Slide Library
Abstract Library

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Mission Statement
Board of Trustees
Embassy of Education
Board of Advisors/Faculty
2022 GI Fellow Board of Advisors

Other Resources

Journal Abstracts
Hep C Link to Care

Subscribe

Be the first to know about our latest upcoming programs and events!
CLDF

Follow us
Facebook
Twitter
Youtube
LiverQ
The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2022 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.